Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

UCrea Repositorio Abierto de la Universidad de Cantabria
Publicación Artículo científico (JournalArticle)

Enhancer-gene specificity in development and disease

  • Pachano, Tomás
  • Haro Gabicagogeascoa, Endika|||0000-0002-0229-6365
  • Rada Iglesias, Álvaro|||0000-0001-7137-1341
Enhancers control the establishment of spatiotemporal gene expression patterns throughout development. Over the past decade, the development of new technologies has improved our capacity to link enhancers with their target genes based on their colocalization within the same topological domains. However, the mechanisms that regulate how enhancers specifically activate some genes but not others within a given domain remain unclear. In this Review, we discuss recent insights into the factors controlling enhancer specificity, including the genetic composition of enhancers and promoters, the linear and 3D distance between enhancers and their target genes, and cell-type specific chromatin landscapes. We also discuss how elucidating the molecular principles of enhancer specificity might help us to better understand and predict the pathological consequences of human genetic, epigenetic and structural variants., Work in the Rada-Iglesias laboratory is funded by the Ministerio de Ciencia e Innovación and the Agencia Españ ola de Investigación; by the European Regional Development Fund (PGC2018-095301-B-I00 and RED2018-102553-T); by the European Research Council (862022); and by the European Commission (H2020-MSCA-ITN-2019-860002)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Enhancer-gene specificity in development and disease

  • Pachano, Tomás
  • Haro, Endika
  • Rada-Iglesias, Álvaro
Enhancers control the establishment of spatiotemporal gene expression patterns throughout development. Over the past decade, the development of new technologies has improved our capacity to link enhancers with their target genes based on their colocalization within the same topological domains. However, the mechanisms that regulate how enhancers specifically activate some genes but not others within a given domain remain unclear. In this Review, we discuss recent insights into the factors controlling enhancer specificity, including the genetic composition of enhancers and promoters, the linear and 3D distance between enhancers and their target genes, and cell-type specific chromatin landscapes. We also discuss how elucidating the molecular principles of enhancer specificity might help us to better understand and predict the pathological consequences of human genetic, epigenetic and structural variants., Work in the Rada-Iglesias laboratory is funded by the Ministerio de Ciencia e Innovación and the Agencia Española de Investigación; by the European Regional Development Fund (PGC2018-095301-B-I00 and RED2018-102553-T); by the European Research Council (862022); and by the European Commission (H2020-MSCA-ITN-2019-860002)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Protocol to study sufficiency of cis-regulatory elements in mouse embryonic stem cells using a CRISPR-mediated knockin approach

  • Pachano, Tomás
  • Rada-Iglesias, Álvaro
Cis-regulatory elements (CREs) orchestrate the spatiotemporal control of gene expression. The regulatory activity of CREs is typically assessed by reporter assays, in which CREs are studied outside their endogenous context. To circumvent this problem, we developed a CRISPR-Cas9 knockin approach to study CREs in a scar-free genomic context. Here, we describe the design, transfection, and screening protocol to insert CREs in mouse embryonic stem cells. Our strategy can provide important insights into the sufficiency of CREs for gene expression control., Work in the Rada-Iglesias laboratory is supported by the EMBO Young Investigator Programme, grant PGC2018-095301-B-I00 funded by MCIN/AEI /10.13039/501100011033 and by “ERDF A way of making Europe,” grant RED2018-102553-T (REDEVNEURAL 3.0) funded by MCIN/AEI /https://doi.org/10.13039/501100011033, grant ERC CoG “PoisedLogic” (862022) funded by the European Research Council, and grant “ENHPATHY” H2020-MSCA-ITN-2019-860002 funded by the European Commission.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Current challenges in understanding the role of enhancers in disease

  • Zaugg, Judith Barbara
  • Sahlén, Pelin
  • Andersson, Robin
  • Alberich-Jorda, Meritxell
  • Laat, Wouter de
  • Deplancke, Bart
  • Ferrer, Jorge
  • Mandrup, Susanne
  • Natoli, Gioacchino
  • Plewczynski, Dariusz
  • Rada-Iglesias, Álvaro
  • Spicuglia, Salvatore
Enhancers play a central role in the spatiotemporal control of gene expression and tend to work in a cell-type-specific manner. In addition, they are suggested to be major contributors to phenotypic variation, evolution and disease. There is growing evidence that enhancer dysfunction due to genetic, structural or epigenetic mechanisms contributes to a broad range of human diseases referred to as enhanceropathies. Such mechanisms often underlie the susceptibility to common diseases, but can also play a direct causal role in cancer or Mendelian diseases. Despite the recent gain of insights into enhancer biology and function, we still have a limited ability to predict how enhancer dysfunction impacts gene expression. Here we discuss the major challenges that need to be overcome when studying the role of enhancers in disease etiology and highlight opportunities and directions for future studies, aiming to disentangle the molecular basis of enhanceropathies., All authors are members of the EU-funded Innovative Training Network ‘Molecular Basis of Human Enhanceropathies’ (Enhpathy, www.enhpathy.eu) and received funding from the Horizon 2020 research and innovation program under Marie Sklodowska-Curie grant agreement no. 860002., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Changes in PRC1 activity during interphase modulate lineage transition in pluripotent cells

  • Asenjo, Helena G.
  • Alcazar-Fabra, María
  • Espinosa-Martínez, Mencía
  • López-Onieva, Lourdes
  • Gallardo, Amador
  • Dimitrova, Emilia
  • Feldmann, Angelika
  • Pachano, Tomás
  • Martorell-Marugán, Jordi
  • Carmona-Sáez, Pedro
  • Sanchez-Pozo, Antonio
  • Rada-Iglesias, Álvaro
  • Klose, Robert J.
  • Landeira, David
The potential of pluripotent cells to respond to developmental cues and trigger cell differentiation is enhanced during the G1 phase of the cell cycle, but the molecular mechanisms involved are poorly understood. Variations in polycomb activity during interphase progression have been hypothesized to regulate the cell-cycle-phase-dependent transcriptional activation of differentiation genes during lineage transition in pluripotent cells. Here, we show that recruitment of Polycomb Repressive Complex 1 (PRC1) and associated molecular functions, ubiquitination of H2AK119 and three-dimensional chromatin interactions, are enhanced during S and G2 phases compared to the G1 phase. In agreement with the accumulation of PRC1 at target promoters upon G1 phase exit, cells in S and G2 phases show firmer transcriptional repression of developmental regulator genes that is drastically perturbed upon genetic ablation of the PRC1 catalytic subunit RING1B. Importantly, depletion of RING1B during retinoic acid stimulation interferes with the preference of mouse embryonic stem cells (mESCs) to induce the transcriptional activation of differentiation genes in G1 phase. We propose that incremental enrolment of polycomb repressive activity during interphase progression reduces the tendency of cells to respond to developmental cues during S and G2 phases, facilitating activation of cell differentiation in the G1 phase of the pluripotent cell cycle., The Landeira lab is supported by the Spanish ministry of science and innovation (PID2019-108108-100, EUR2021-122005), the Andalusian regional government (PIER-0211-2019, PY20_00681) and the University of Granada (A-BIO-6-UGR20) grants. Research in the Klose lab is supported by the Wellcome Trust (209400/Z/17/Z) and the European Research Council (681440). A.F. was supported by a Sir Henry Wellcome Post-doctoral fellowship (110286/Z/15/Z). Work in the Rada-Iglesias lab is funded by the Ministerio de Ciencia e Innovación, the Agencia Española de Investigación and the European Regional Development Fund (PGC2018-095301-B-I00 and RED2018-102553-T); by the European Research Council (862022); and by the European Commission (H2020-MSCA-ITN-2019-860002)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

POSTRE: A tool to predict the pathological effects of human structural variants

  • Sánchez-Gaya, Víctor
  • Rada-Iglesias, Álvaro
Understanding the pathological impact of non-coding genetic variation is a major challenge in medical genetics. Accumulating evidences indicate that a significant fraction of genetic alterations, including structural variants (SVs), can cause human disease by altering the function of non-coding regulatory elements, such as enhancers. In the case of SVs, described pathomechanisms include changes in enhancer dosage and long-range enhancer-gene communication. However, there is still a clear gap between the need to predict and interpret the medical impact of non-coding variants, and the existence of tools to properly perform these tasks. To reduce this gap, we have developed POSTRE (Prediction Of STRuctural variant Effects), a computational tool to predict the pathogenicity of SVs implicated in a broad range of human congenital disorders. By considering disease-relevant cellular contexts, POSTRE identifies SVs with either coding or long-range pathological consequences with high specificity and sensitivity. Furthermore, POSTRE not only identifies pathogenic SVs, but also predicts the disease-causative genes and the underlying pathological mechanism (e.g, gene deletion, enhancer disconnection, enhancer adoption, etc.)., Víctor Sánchez-Gaya is supported by a doctoral fellowship from the University of Cantabria (Spain); Work in the Rada-Iglesias laboratory is supported by the EMBO Young Investigator Programme [PGC2018-095301-B-I00, PID2021-123030NB-I00] funded by MCIN/AEI/10.13039/501 100 011 033 and by ‘ERDF A way of making Europe’ [RED2018-102553-T (REDEVNEURAL 3.0)] funded by MCIN/AEI/10.13039/501 100 011 033; ERC CoG ‘PoisedLogic’ [862 022] funded by the European Research Council and grant ‘ENHPATHY’ H2020-MSCA-ITN-2019-860002 funded by the European Commission.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The interaction between enhancer variants and environmental factors as an overlooked aetiological paradigm in human complex disease

  • Robert, Sarah
  • Rada-Iglesias, Álvaro
The interactions between genetic and environmental risk factors contribute to the aetiology of complex human diseases. Genome-wide association studies (GWAS) have revealed that most of the genetic variants associated with complex diseases are located in the non-coding part of the genome, preferentially within enhancers. Enhancers are distal cis-regulatory elements composed of clusters of transcription factors binding sites that positively regulate the expression of their target genes. The generation of genome-wide maps for histone marks (e.g., H3K27ac), chromatin accessibility and transcription factor and coactivator (e.g., p300) binding profiles have enabled the identification of enhancers across many human cell types and tissues. Nonetheless, the functional and pathological consequences of the majority of disease-associated genetic variants located within enhancers seem to be rather minor under normal conditions, thus questioning their medical relevance. Here we propose that, due to the prevalence of enhancer redundancy, the pathological effects of many disease-associated non-coding genetic variants might be preferentially (or even only) manifested under environmental stress., Sarah Robert is supported by ‘ENHPATHY’ H2020-MSCA-ITN-2019-860002. Work in the Rada-Iglesias laboratory is supported by grants PID2021-123030NB-I00 funded by MCIN/AEI/10.13039/501100011033, grant ERC CoG ‘PoisedLogic’ (862022) funded by the European Research Council and grant ‘ENHPATHY’ H2020-MSCA-ITN-2019-860002 funded by the European Commission., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Understanding enhancer function to understand human disease

  • Spicuglia, Salvatore
  • Rada-Iglesias, Álvaro
In multicellular organisms, spatial and temporal regulation of gene expression is crucial for development, cellular differentiation, and homeostasis. Cell-type-specific regulation of gene expression is achieved through the interaction between regulatory elements that are either proximal (promoters) or distal (enhancers, silencers, insulators) to gene transcription start sites (TSSs). Enhancers, which primarily function in a cell type-specific manner, are short (100–1000 bp) DNA sequences that contain binding sites for transcription factors and increase the expression of their target genes in cis. Four decades after their first discovery, enhancers are now widely considered key elements in the spatiotemporal control of gene expression underlying human development and homeostasis. Furthermore, enhancers play a significant role in disease, evolution, and phenotypic diversity. From a medical point of view, accumulating evidence indicate that a wide spectrum of human disorders, known as enhanceropathies, are influenced by enhancer malfunction caused by genetic, structural, or epigenetic alterations. These processes can directly cause cancer or Mendelian disorders, while they can also underpin the susceptibility to many common diseases. Despite recent advances in our understanding of enhancer biology and function, our capacity to foresee how enhancer dysfunction affects gene expression and, thus, human disease, is still limited. Therefore, elucidating the molecular basis of enhancer function in healthy and disease states has far-reaching translational implications, as it can help improving the diagnosis and therapeutic intervention of a broad range of human disorders., The preparation of the special issue has been done with the support of the “Enhpathy” Marie Sklodowska-Curie actions (MSCA)—Innovative Training Network (ITN) funded by the European Union's Horizon 2020 research and innovation program (Grant Number: 860002).
UCrea Repositorio Abierto de la Universidad de Cantabria
Publicación Tesis doctoral (DoctoralThesis)

Predicción de los mecanismos patogénicos de largo alcance de las variantes estructurales en enfermedades humanas congénitas, Predicting the pathogenic long-range effects of structural variation in human congenital disease

  • Sánchez Gaya, Víctor
Ser capaces de interpretar la variabilidad genética presente en cada individuo y su relación con el desarrollo de enfermedades, es uno de los mayores retos a los que se enfrenta la medicina en los próximos años. Uno de los factores limitantes que existen en este campo son las dificultades para comprender los mecanismos patogénicos desencadenados por alteraciones en regiones no codificantes del genoma. Esto viene causado, en parte, por la falta de conocimiento de la regulación de la expresión génica mediada por potenciadores. En este trabajo he presentado una herramienta computacional, llamada POSTRE, que contribuirá a la mejora de la interpretación de los efecto patológicos de las variantes estructurales en enfermedades congénitas causadas por la alteración de la comunicación entre genes y potenciadores. Además, nuestro estudio de la función de las islas CpG ha mostrado como su presencia en promotores y potenciadores es de suma relevancia para permitir su comunicación., Being able to interpret the genetic variability present in each individual and its relationship with the development of diseases, is one of the greatest challenges faced by medicine in the coming years. One of the limiting factors in this field are the difficulties in understanding the pathogenic mechanisms triggered by alterations in non-coding regions of the genome. This is caused, in part, by the lack of knowledge of enhancer-mediated regulation of gene expression. In this work I have presented a computational tool, called POSTRE, which will contribute to improve the interpretation of the pathological effects of structural variants in congenital diseases caused by the alteration of gene-enhancer communication. In addition, our study of the function of CpG islands has shown how their presence in promoters and enhancers is of utmost relevance to enable their communication., Esta tesis doctoral ha sido realizada principalmente gracias a una ayuda predoctoral financiada por la Universidad de Cantabria, el Instituto de Investigación Marqués de Valdecilla (IDIVAL), la consejería de Universidades e Investigación, Medio Ambiente y Política Social, y la Consejería de Sanidad del Gobierno de Cantabria. Además, el trabajo en el laboratorio de Álvaro Rada Iglesias cuenta con el apoyo del Programa de Jóvenes Investigadores de la EMBO [PGC2018- 095301-BI00, PID2021-123030NB-I00] financiado por MCIN/AEI/10.13039/501 100 011 033 y por 'ERDFA way of making Europe' [RED2018-102553-T (REDE- VNEURAL 3. 0)] respaldado por MCIN/AEI/10.13039/501 100 011 033. Dispone también de fondos del Consejo Europeo de Investigación, ERC CoG 'PoisedLogic' [862 022], además de la subvención 'ENHPATHY' H2020-MSCA-ITN-2019-860002 financiada por la Comisión Europea.
UCrea Repositorio Abierto de la Universidad de Cantabria
Publicación Artículo científico (JournalArticle)

Dual role of ZIC2 during neural induction: from priming transcription factor to enhancer activator

  • Mariner Faulí, María
  • Sánchez Gaya, Víctor
  • Robert, Sarah Malika
  • Respuela Alonso, Patricia
  • Cruz Molina, Sara de la
  • Lobato-moreno, Sara
  • Trovato, Matteo
  • Prummel, Karin D.
  • Noh, Kyung-Min
  • Zaugg, Judith B.
  • Rada Iglesias, Álvaro|||0000-0001-7137-1341
Defects in ZIC2, a member of the Zinc Finger of the Cerebellum family of transcription factors (TFs), cause holoprosencephaly, a congenital brain malformation characterized by the defective cleavage of cerebral hemispheres. However, the gene regulatory network (GRN) controlled by ZIC2 during neural development remains largely unexplored. Here, we combined a mouse embryonic stem cell (mESC) in vitro differentiation model toward anterior neural progenitors with genome editing and genomic methods to elucidate the ZIC2 GRN. We found that ZIC2 is dispensable in mESC due to compensation by ZIC3. In contrast, during neural induction ZIC2 directly controls the expression of master regulators implicated in the patterning and morphogenesis of specific brain regions (e.g. midbrain and roof plate). Mechanistically, ZIC2 plays a dual role in neural differentiation: during pluripotency exit, ZIC2 binds de novo to distal enhancers and increases their chromatin accessibility; during neural induction, ZIC2 is essential for the activation of a subset of the previously primed enhancers, which in turn control the expression of neural patterning regulators and signalling pathways (i.e. WNT) that prevent premature neuronal differentiation. Therefore, by sequentially acting as a promiscuous priming TF and selective enhancer activator, ZIC2 canalizes pluripotent cells toward neural progenitors with rostro-dorsal identities., M.M.F. acknowledges the support of the EMBO Scientific Exchange Grant, which funded her internship at EMBL Heidelberg during which the single-cell multiomic data were generated. M.M.F. PhD was supported by a Grant for Pre-doctoral Contracts for the Training of Researchers – FPI National Subprogram for Training (Ref: PRE2019- 089037). Work in the Rada-Iglesias laboratory is supported by the following grants: PID2021-123030NB-I00 (AR-I), funded by MCIN/AEI/10.13039/501100011033 and by ERDF “A way of making Europe”; RED2022- 134100-T (AR-I) (REDEVNEURAL 3.0), funded by MCIN/AEI/10.13039/501100011033; ERC Consolidator Grant PoisedLogic (862022) (AR-I), funded by the European Research Council; ENHPATHY H2020-MSCAITN-2019–860002 (AR-I), funded by the European Commission; and Chromrare HORIZON- MSCA-2021-DN01–101073334 (AR-I), also funded by the European Commission. Funding to pay the Open Access publication charges for this article was provided by the European Research Council Consolidator grant.
UCrea Repositorio Abierto de la Universidad de Cantabria
Publicación Artículo científico (JournalArticle)

Cooperative insulation of regulatory domains by CTCF-dependent physical insulation and promoter competition

  • Ealo Rodríguez, Thais
  • Sánchez Gaya, Víctor
  • Respuela Alonso, Patricia
  • Muñoz San Martín, María |||0000-0002-7249-5343
  • Martín-Batista, Elva
  • Haro Gabicagogeascoa, Endika|||0000-0002-0229-6365
  • Rada Iglesias, Álvaro|||0000-0001-7137-1341
The specificity of gene expression during development requires the insulation of regulatory domains to avoid inappropriate enhancer-gene interactions. In vertebrates, this insulator function is mostly attributed to clusters of CTCF sites located at topologically associating domain (TAD) boundaries. However, TAD boundaries allow some physical crosstalk across regulatory domains, which is at odds with the specific and precise expression of developmental genes. Here we show that developmental genes and nearby clusters of CTCF sites cooperatively foster the robust insulation of regulatory domains. By genetically dissecting a couple of representative loci in mouse embryonic stem cells, we show that CTCF sites prevent undesirable enhancer-gene contacts (i.e. physical insulation), while developmental genes preferentially contribute to regulatory insulation through non-structural mechanisms involving promoter competition rather than enhancer blocking. Overall, our work provides important insights into the insulation of regulatory domains, which in turn might help interpreting the pathological consequences of certain structural variants., Acknowledgements: We would like to thank all the Rada-Iglesias lab members for insightful comments and suggestions. Work in the Rada-Iglesias laboratory is supported by grant PID2021-123030NB-I00 (AR-I) funded by MCIN/AEI/ 10.13039/501100011033 and by ERDF A way of making Europe, grant RED2022-134100-T (AR-I) (REDEVNEURAL 3.0) funded by MCIN/AEI /10.13039/501100011033, grant ERC CoG PoisedLogic (862022) (A.R.-I.) funded by the European Research Council, grant ENHPATHY H2020-MSCA-ITN-2019-860002 (A.R.-I.) funded by the European Commission, grant Chrom_rare HORIZON-MSCA-2021-DN-01-101073334 (A.R.-I.) funded by the European Commission. E.M.B was granted with a fellowship from the network PIE-202120E047-Conexiones-Life.
UCrea Repositorio Abierto de la Universidad de Cantabria
Publicación Tesis doctoral (DoctoralThesis)

Caracterización genómica y mecanística de la función de ZIC2 durante la inducción neural in vitro, Genomic and mechanistic characterization of ZIC2 function during in vitro neural induction

  • Mariner Faulí, María
ZIC2, miembro de la familia de factores de transcripción Zinc Finger of the Cerebellum, desempeña funciones cruciales durante el desarrollo neural. Defectos en ZIC2 dan lugar a holoprosencefalia (HPE), una malformación congénita caracterizada por la división defectuosa de los hemisferios cerebrales. En la actualidad, se desconoce la red de regulación génica exacta controlada por ZIC2 y su mecanismo regulador preciso. Aquí, mostramos que ZIC2 posee una función dual a lo largo de la diferenciación neural: (i) durante la salida de pluripotencia, ZIC2 actúa como un factor de transcripción pionero, promoviendo la accesibilidad de la cromatina de un conjunto de regiones potenciadoras distales; (ii) durante la inducción neural, ZIC2 es esencial para la activación de un subconjunto de potenciadores que controlan la expresión de genes implicados en patterning y morfogénesis de regiones cerebrales específicas. Esta tesis caracteriza el papel de ZIC2 en el establecimiento del paisaje de potenciadores neurales y proporciona información sobre la HPE, ZIC2, a member of the Zinc Finger of the Cerebellum family of transcription factors, plays crucial roles during neural development. Defects in ZIC2 lead to holoprosencephaly (HPE), a congenital brain malformation characterized by the defective cleavage of cerebral hemispheres. However, little is known about the exact gene regulatory network controlled by this transcription factor, as well as the precise regulatory mechanism employed to perform its function. Here, we show that ZIC2 plays a dual regulatory role throughout neural differentiation: (i) during pluripotency exit, ZIC2 acts as a pioneer transcription factor, promoting chromatin accessibility at a broad set of distal enhancer regions; (ii) during neural induction, ZIC2 is essential for the activation of a subset of enhancers controlling the expression of neural genes involved in patterning and morphogenesis of specific brain regions. This thesis characterizes the role of ZIC2 in the establishment of the neural enhancer landscape and provides insights into ZIC2-related holoprosencephaly., La realización de este proyecto de tesis doctoral ha sido posible gracias a la obtención de financiación proveniente de las siguientes fuentes: • AYUDAS PARA CONTRATOS PREDOCTORALES PARA LA FORMACIÓN DE DOCTORES SUBPROGRAMA ESTATAL DE FORMACIÓN FPI. Referencia: PRE2019-089037. • Programa de Jóvenes Investigadores de la EMBO (EMBO YIP). • Planes estatales PGC2018- 095301-B-I00 y PID2021-123030NB-I00 financiados por MCIN/AEI/10.13039/501 100 011 033 y por 'ERDF A way of making Europe'. • RED2022-134100-T (REDEVNEURAL 3.0) financiada por MCIN/AEI/10.13039/501100011033. • Consejo Europeo de Investigación, ERC CoG 'PoisedLogic' [862 022]. • ENHPATHY' H2020-MSCA-ITN-2019-860002 financiada por la Comisión Europea. • EMBO Scientific Exchange Grant 9842.
UCrea Repositorio Abierto de la Universidad de Cantabria
Publicación Tesis doctoral (DoctoralThesis)

Modelización in vitro de la holoprosencefalia relacionada con ZIC2 en humanos revela genes diana sensibles a la dosis de ZIC2, In vitro disease modelling of human ZIC2-related holoprosencephaly unconvers dosage-sensitive ZIC2 target genes

  • Robert, Sarah Malika|||0009-0002-7692-2776
Durante el desarrollo, los factores de transcripción (TFs) juegan un papel clave en garantizar el establecimiento robusto de los programas de expresión génica y, por lo tanto, de las identidades celulares. En este trabajo, investigamos el papel del factor de transcripción ZIC2 durante la inducción de identidades neuronales anteriores. La relevancia del gen ZIC2 se destaca por su asociación con la holoprosencefalia (HPE), un trastorno congénito del prosencéfalo que afecta la correcta separación de los hemisferios cerebrales. A pesar de su importancia médica y en el desarrollo, se sabe poco sobre la red reguladora controlada por ZIC2 durante el desarrollo del prosencéfalo, especialmente en humanos. Por ello, aprovechamos el sistema de diferenciación de hiPSCs hacia células progenitoras neuronales anteriores (AntNPCs) para estudiar la red reguladora controlada por ZIC2 durante la inducción neural. Combinando métodos de edición genética con CRISPR-Cas9 y análisis genómicos, demostramos que la ausencia de ZIC2 provoca un aumento en la expresión de marcadores del telencéfalo rostral, una reducción en la señalización WNT y en los marcadores del cortical hem; además, ZIC2 se une y es necesario para activar potenciadores distales asociados a reguladores clave del patrón del prosencéfalo. También observamos haploinsuficiencia de ZIC2 en AntNPCs. En conjunto, este trabajo ofrece nuevas perspectivas sobre la red reguladora controlada por ZIC2 durante la organización del prosencéfalo humano, lo cual puede contribuir a entender la base molecular de la HPE., During development, transcription factors (TFs) play a key role in ensuring the robust establishment of gene expression programs and, thus, of cellular identities. In this work, investigated the role of the TF ZIC2 during the induction of anterior neural identities. The relevance of the ZIC2 gene is highlighted by its association with holoprosencephaly (HPE), a forebrain congenital disorder affecting the proper separation of the cerebral hemispheres. Despite the medical and developmental relevance of ZIC2, little is known about the regulatory network controlled by this TF during forebrain development, particularly in humans. We therefore took advantage of hiPSCs and differentiated them into anterior neural progenitor cells (AntNPCs) with a forebrain-like identity to study the regulatory network controlled by ZIC2 upon neural induction. Combining CRISPR-Cas9 genome editing approaches and genomic methods, we showed that in the absence of ZIC2, AntNPCs showed increased expression of rostral telencephalon markers and reduced levels of WNT signaling and cortical hem markers; ZIC2 binds to and is required for the activation of distal enhancers associated with major forebrain patterning regulators and that AntNPC display ZIC2 haploinsufficiency. Altogether, this work provides novel insights into the regulatory network controlled by ZIC2 during human forebrain patterning, which in turn can help understanding the molecular basis of HPE., La realización de este proyecto de tesis doctoral ha sido posible gracias a la obtención de financiación proveniente de las siguientes fuentes: • Programa de Jóvenes Investigadores de la EMBO (EMBO YIP). • Planes estatales PGC2018- 095301-B-I00 y PID2021-123030NB-I00 financiados por MCIN/AEI/10.13039/501 100 011 033 y por 'ERDF A way of making Europe'. • RED2022-134100-T (REDEVNEURAL 3.0) financiada por MCIN/AEI/10.13039/501100011033. • Consejo Europeo de Investigación, ERC CoG 'PoisedLogic' [862 022]. • ENHPATHY' H2020-MSCA-ITN-2019-860002 financiada por la Comisión Europea.